Page last updated: 2024-12-07

3-mercaptopropanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-mercaptopropanol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID88211
CHEMBL ID3234722
MeSH IDM0508225

Synonyms (38)

Synonym
19721-22-3
nsc-46437
nsc46437
3-sulfanylpropan-1-ol
3-hydroxypropyl mercaptan
3-hydroxypropanethiol
3-mercapto-1-propanol
1-propanol, 3-mercapto-
3-sulfanyl-1-propanol
3-mercapto-1-propanol, 95%
3-mercaptopropanol
inchi=1/c3h8os/c4-2-1-3-5/h4-5h,1-3h2
shlsslvzxjbvhe-uhfffaoysa-
M1206
einecs 264-572-5
wy6f8yvc7z ,
nsc 46437
unii-wy6f8yvc7z
FT-0615945
AKOS015898616
CHEMBL3234722
3-mercaptopropan-1-ol
3-hydroxypropylmercaptan
3-mecapto-1-propanol
3-mercapto-propan-1-ol
3-mecaptopropan-1-ol
cas-19721-22-3
NCGC00357168-01
tox21_303927
dtxsid3051836 ,
dtxcid8030392
1-mercapto-3-propanol
3-sulfanyl-1-propanol #
mfcd00192262
J-012747
PS-17830
D78398
EN300-87411
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1128913Inhibition of metallo-beta-lactamase IMP-1 (unknown origin)2014European journal of medicinal chemistry, Apr-09, Volume: 76The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-β-lactamases and arginases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.81 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]